May 16, 2023 The future of the assisted reproductive technology (ART): Modernising ART processes with AI By Nicholas Tyacke Greg Bodulovic Alexandra de Zwart Abi Ketheeswaran +1 more... Show less Assisted fertilisation processes involve striking the perfect balance between a range of complex factors – all of which play a critical...
Apr 28, 2023 The UK voluntary scheme for branded medicines pricing and access (VPAS): just what the doctor ordered, or a bitter pill to swallow? By Michael Stead Martha Pownall On the 1 April this year, amidst storm clouds gathering above the NHS in the form of staffing strikes, record waiting times and chronic...
Mar 10, 2023 Poland - Life Sciences monthly brief, February 2023 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our January monthly briefing, which covers key updates and insights in the following areas: Medicinal productsClinical...
Feb 09, 2023 Portugal: A transformation of the healthcare system may be under way By Mariana Ricardo Pharmacies have always played a relevant role in healthcare in Portugal, where pharmacists and pharmacy technicians traditionally share...
Feb 01, 2023 Working on the affordability of medicines: 2023 begins with an important message on excessive pricing - Portugal By Mariana Ricardo Early this year, the Portuguese Minister of Health stated the public expense with medicines in 2022 showed an increase of more than EUR...
Oct 20, 2022 The potential for unintended consequences in the Inflation Reduction Act By Jim Greenwood Alex Pinson Jamie Gregorian The Inflation Reduction Act (IRA) significantly impacts the US economic model for prescription drug innovation through the imposition of...
Jun 13, 2022 Summer of 2022; the dawn of the behemoth, Haleon plc By Robert Newman Think back almost four years to December 2018. A certain Donald Trump was POTUS, Theresa May survived a vote of no confidence (by a vote...
Apr 04, 2022 MHRA announce new scheme for monitoring good manufacturing and distributions practices in IAG cases By Taryn Jones Teresa Hitchcock The Medicines & Healthcare products Regulatory Agency (MHRA) has announced a new supervisory scheme as part of its process for monitoring...
Mar 16, 2022 UK ABPI calls for standardised international approach to university-industry collaborations By Richard Taylor Anna Wrench The Association of the British Pharmaceutical Industry (ABPI, the UK’s leading association for pharmaceutical companies), has published a...
Feb 18, 2022 Clinical Trial Regulations in the EU – how will the UK follow? By Kate Burgess The European Medicines Agency has confirmed that the new Clinical Trials Regulation is now in effect as of 31 January 2022. Please see...
Feb 08, 2022 An analysis of the effect of drug pricing provisions in the Build Back Better Act on pharmaceutical innovation By Kirsten Axelsen Having previously examined the impact of implementing international reference pricing in the United States, Charles River Associates (a...
Jan 17, 2022 Legislative initiative on off-label prescription By Vadim Barbu Off-label use of medication is currently not regulated in Romania. Rather, it is up to the doctors to decide on the off-label use of a...
Dec 13, 2021 Do medical devices have systematic bias? By Kate Burgess Anna Ward An investigation has been launched by the UK’s Department of Health and Social Care (“DHSC”) with the overall aim of improving healthcare...
Nov 17, 2021 Assessing the value of medicine for diverse patients: Implications of a QALY approach for health disparities By Kirsten Axelsen Momentum and debate about the application of cost-effectiveness analysis to determine the value and prices of prescription drugs in the...
Nov 11, 2021 The unhealthy healthcare system – a view on the treatment of medical waste By Inês Santana Metello Mariana Ricardo Countries and industries have been progressively setting ‘net zero’ targets, adapting legislation and activities to move towards a...
Oct 04, 2021 Update: Poland - Plan for Rare Diseases for 2021-2023 By Amelia Prawda In the last week of September 2021, the Polish Cabinet finally published the Plan for Rare Diseases for...